• Hetzer Medical Indonesia told the IDX it knew of no undisclosed material information behind MEDS share volatility.
• Stock jumped IDR 25 to IDR 97 on Sept. 7, up 34.72% from IDR 72, hitting the upper auto-reject limit.
• Trading volume surged to 1,173,817,400 shares from 18,218,100 shares in the prior session.
• Management said it had no near-term corporate actions planned, including any that could affect the listing.
• Controlling shareholders signaled no plans to change their stake; the firm cited no other material events not yet disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Hetzer Medical Indonesia Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32146698) on September 09, 2026, and is solely responsible for the information contained therein.